Cover Image
Market Research Report
Product code

Nigeria Clinical Laboratory Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Published: | Mordor Intelligence Pvt Ltd | 75 Pages | Delivery time: 2-3 business days


Back to Top
Nigeria Clinical Laboratory Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
Published: April 21, 2021
Mordor Intelligence Pvt Ltd
Content info: 75 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents

The Nigerian clinical laboratory services market was valued at USD 504 million in 2020 and it is expected to reach USD 665 million in 2026, by registering a CAGR of 4.7% during the forecast period.

The clinical laboratory market has been affected by the ongoing COVID-19 pandemic. However, the market for COVID diagnostic services is positively impacting the market, as the number of cases is rising every day and there is high demand for COVID diagnostic services in Nigeria. According to an article published in the International Journal of Infectious Diseases, 2020, the incidence rate of COVID-19 is growing steadily in Nigeria. The Government of Nigeria is continuously focusing on remote diagnostics, case management, and the expansion of telemedicine solutions, which may fulfill the unmet needs during the ongoing pandemic.

The Nigerian Clinical laboratory market is driven by the rising incidences of chronic diseases and the increasing demand for accurate disease diagnosis, along with the government's focus on public-private partnerships. According to the data published on the Global Health Data Exchange, the top causes of death in Nigeria are malaria, lower respiratory infections, HIV/AIDS, diarrheal diseases, cancer, meningitis, stroke, and tuberculosis. The number of malaria cases was around 58,143,458 and the number of deaths caused by malaria was around 191,106, in 2019. According to the same source, the number of tuberculosis cases was 288,258 and the number of cases for diarrheal diseases was around 244,501,556, in 2019. Thus, the prevalence of infectious diseases is rising in the country, which is augmenting the demand for diagnostic services for the better management of diseases.

In addition, the Nigerian government, donor agencies, and NGOs are also making collaborative efforts to raise awareness among individuals. In August 2019, Memfys Hospital and GE Healthcare collaborated to improve the disease diagnosis in the southeast regions of Nigeria. However, the lack of medical laboratories, advanced diagnostic equipment, and inadequately trained laboratory staff are restraining the market's growth.

Key Market Trends

The Microbiology Testing Expected to Hold the Significant Market Share

By Speciality, microbiology testing is anticipated to share a healthy market share during the forecast period. Microbiology testing refers to the diagnostic testing of infectious diseases caused by microorganisms, such as bacteria and viruses. The high burden of infectious diseases in Nigeria and increasing awareness of and accessibility to microbiology testing are likely to drive the segment growth in the country.

According to the UNAIDS' 2018 data, Nigeria had the second-largest HIV epidemic in the world and one of the highest rates of new infection in sub-Saharan Africa. As of 2018, 1.9 million people in Nigeria were living with AIDS; however, deaths due to AIDS have reduced significantly. AIDS-related deaths have declined since 2010, with a 26% decrease, from 72,000 deaths to 53,000 deaths, as there is increased awareness about the early diagnosis and treatment of the disease.

Similarly, according to the article published by Ahmad Muhammad Njidda, 2017 saw an increase in the rate of infectious diseases, like Lassa fever, yellow fever, monkeypox, cholera, and new strains of existing pathogens like Neisseria meningitides serogroup C in Nigeria.

Moreover, owing to the COVID 19 pandemic, there has been an increase in demand for the country's microbiology testing services. Hence, the laboratories have focused on expanding the testing capacity. For instance, in April 2020, 54Gene increased Nigeria's laboratory testing capacity for COVID-19 with a mobile laboratory in Ogun. Thus, the market for microbiology testing is likely to show growth over the forecast period in Nigeria.

Competitive Landscape

The market concentration of the Nigerian clinical laboratory services market is high, and some major players are currently dominating the market. These major players include Mecure Healthcare Limited, Union Diagnostic and Clinical Services PLC, Echo-Scan Services Limited, and Synlab Bondco PLC. However, there are some mid-sized companies that are focusing on market penetration, and they are expected to hold a substantial share in the market during the forecast period.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Table of Contents
Product Code: 58871



  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic Infectious Diseases
    • 4.2.2 Rising Demand for Accurate Disease Diagnosis
    • 4.2.3 Public-Private Partnerships
  • 4.3 Market Restraints
    • 4.3.1 Lack of Medical Laboratories and Advanced Diagnostic Equipment
    • 4.3.2 Inadequately Trained Laboratory Staff
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Specialty
    • 5.1.1 Clinical Chemistry Testing
    • 5.1.2 Microbiology Testing
    • 5.1.3 Hematology Testing
    • 5.1.4 Immunology Testing
    • 5.1.5 Cytology Testing
    • 5.1.6 Genetic Testing
    • 5.1.7 Other Specialties
  • 5.2 By Provider
    • 5.2.1 Independent and Reference Laboratories
    • 5.2.2 Hospital-based Laboratories


  • 6.1 Company Profiles
    • 6.1.1 Mecure Healthcare Ltd
    • 6.1.2 Union Diagnostic And Clinical Services PLC
    • 6.1.3 Echo Lab (Integrated Diagnostic Holdings)
    • 6.1.4 Synlab Bondco PLC
    • 6.1.5 Afriglobal Medicare Ltd
    • 6.1.6 Medicaid Radiology Ltd
    • 6.1.7 Lancet Laboratories (CLINA LANCET)
    • 6.1.8 LifeBridge Diagnostic Center